{"id":{"repo_id":"uconn-diss","oai_identifier":"oai:digitalcommons.lib.uconn.edu:gs_theses-1038"},"canonical_url":"https://search.dev.ndltd.org/etd/uconn-diss/oai:digitalcommons.lib.uconn.edu:gs_theses-1038","repository":{"repo_id":"uconn-diss","name":"University of Connecticut","base_url":"https://digitalcommons.lib.uconn.edu/do/oai/"},"display":{"title":"The Influence of Neurocognitive Impairment on Treatment Outcomes among Drug-involved People Living with HIV/AIDS","abstract":"<p>Drug- and sex-related HIV risk behaviors and sub-optimal adherence to HIV medication regimens can jeopardize the health of HIV–infected injection drug users (IDUs) and threaten community health. Findings to date indicate that it is feasible to deliver a brief behavioral risk reduction/medication adherence group intervention to HIV-infected IDUs in a community-based setting. Being adherent to HAART or being able to successfully participate in behavioral interventions targeting adherence and harm reduction often requires a relatively high level of cognitive abilities. HIV infection and substance abuse are known to independently affect the central nervous system and this can result in neuro-cognitive impairment. In combination, their effects can be even more profound and this is directly relevant to intervention development because a significant number of people living with HIV/AIDS have a positive history of substance abuse. AIM: To evaluate if changes in information, motivation and behavior skills (IMB) with respect to medication adherence, sex- and drug-risk behavior outcomes is predicted by cognitive impairment following the brief 4-session Community-Friendly Health Recovery Program for HIV-infected Drug Users (CHRP+). Findings suggest that it may be helpful to specifically tailor such behavioral interventions to accommodate cognitive impairment.</p>","abstract_html":"&lt;p&gt;Drug- and sex-related HIV risk behaviors and sub-optimal adherence to HIV medication regimens can jeopardize the health of HIV–infected injection drug users (IDUs) and threaten community health. Findings to date indicate that it is feasible to deliver a brief behavioral risk reduction/medication adherence group intervention to HIV-infected IDUs in a community-based setting. Being adherent to HAART or being able to successfully participate in behavioral interventions targeting adherence and harm reduction often requires a relatively high level of cognitive abilities. HIV infection and substance abuse are known to independently affect the central nervous system and this can result in neuro-cognitive impairment. In combination, their effects can be even more profound and this is directly relevant to intervention development because a significant number of people living with HIV/AIDS have a positive history of substance abuse. AIM: To evaluate if changes in information, motivation and behavior skills (IMB) with respect to medication adherence, sex- and drug-risk behavior outcomes is predicted by cognitive impairment following the brief 4-session Community-Friendly Health Recovery Program for HIV-infected Drug Users (CHRP+). Findings suggest that it may be helpful to specifically tailor such behavioral interventions to accommodate cognitive impairment.&lt;/p&gt;","abstract_has_math":false,"creators":["Ezeabogu, Ifeoma O"],"institution":null,"degree_name":"Master of Science","degree_level":null,"degree_discipline":"Allied Health","degree_department":null,"school":null,"contributors":["Pouran Faghri; Declan Barry","Michael Copenhaver"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010-12-18T08:00:00Z","date_published":"2010-12-18T08:00:00Z","updated_at":"2026-07-24T06:31:35Z","subjects":["HIV/AIDS","Injection drug use","Neurocognitive impairment","ART Medication adherence","Risk Behavior","Behavioral therapy","Information Motivation Behavior Skill model","Neuropsychological impairment Scale"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.lib.uconn.edu/gs_theses/31","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Pouran Faghri; Declan Barry","Michael Copenhaver"]},{"key":"dc:creator","label":"Author","values":["Ezeabogu, Ifeoma O"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2011-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Allied Health"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["HIV/AIDS","Injection drug use","Neurocognitive impairment","ART Medication adherence","Risk Behavior","Behavioral therapy","Information Motivation Behavior Skill model","Neuropsychological impairment Scale"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.lib.uconn.edu/gs_theses/31"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Drug- and sex-related HIV risk behaviors and sub-optimal adherence to HIV medication regimens can jeopardize the health of HIV–infected injection drug users (IDUs) and threaten community health. Findings to date indicate that it is feasible to deliver a brief behavioral risk reduction/medication adherence group intervention to HIV-infected IDUs in a community-based setting. Being adherent to HAART or being able to successfully participate in behavioral interventions targeting adherence and harm reduction often requires a relatively high level of cognitive abilities. HIV infection and substance abuse are known to independently affect the central nervous system and this can result in neuro-cognitive impairment. In combination, their effects can be even more profound and this is directly relevant to intervention development because a significant number of people living with HIV/AIDS have a positive history of substance abuse. AIM: To evaluate if changes in information, motivation and behavior skills (IMB) with respect to medication adherence, sex- and drug-risk behavior outcomes is predicted by cognitive impairment following the brief 4-session Community-Friendly Health Recovery Program for HIV-infected Drug Users (CHRP+). Findings suggest that it may be helpful to specifically tailor such behavioral interventions to accommodate cognitive impairment.</p>"]},{"key":"dc:title","label":"Title","values":["The Influence of Neurocognitive Impairment on Treatment Outcomes among Drug-involved People Living with HIV/AIDS"]}]}],"canonical_facts":{"dc:contributor":["Pouran Faghri; Declan Barry","Michael Copenhaver"],"dc:creator":["Ezeabogu, Ifeoma O"],"dc:date.available":["2011-01-01T08:00:00Z"],"dc:description.abstract":["<p>Drug- and sex-related HIV risk behaviors and sub-optimal adherence to HIV medication regimens can jeopardize the health of HIV–infected injection drug users (IDUs) and threaten community health. Findings to date indicate that it is feasible to deliver a brief behavioral risk reduction/medication adherence group intervention to HIV-infected IDUs in a community-based setting. Being adherent to HAART or being able to successfully participate in behavioral interventions targeting adherence and harm reduction often requires a relatively high level of cognitive abilities. HIV infection and substance abuse are known to independently affect the central nervous system and this can result in neuro-cognitive impairment. In combination, their effects can be even more profound and this is directly relevant to intervention development because a significant number of people living with HIV/AIDS have a positive history of substance abuse. AIM: To evaluate if changes in information, motivation and behavior skills (IMB) with respect to medication adherence, sex- and drug-risk behavior outcomes is predicted by cognitive impairment following the brief 4-session Community-Friendly Health Recovery Program for HIV-infected Drug Users (CHRP+). Findings suggest that it may be helpful to specifically tailor such behavioral interventions to accommodate cognitive impairment.</p>"],"dc:identifier":["https://digitalcommons.lib.uconn.edu/gs_theses/31"],"dc:subject":["HIV/AIDS","Injection drug use","Neurocognitive impairment","ART Medication adherence","Risk Behavior","Behavioral therapy","Information Motivation Behavior Skill model","Neuropsychological impairment Scale"],"dc:title":["The Influence of Neurocognitive Impairment on Treatment Outcomes among Drug-involved People Living with HIV/AIDS"],"thesis:degree_discipline":["Allied Health"],"thesis:degree_name":["Master of Science"]},"updated_at":"2026-07-24T06:31:35Z"}